These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8499957

  • 1. Oral versus transdermal hormone replacement therapy.
    Stevenson JC, Crook D, Godsland IF, Lees B, Whitehead MI.
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():30-5. PubMed ID: 8499957
    [Abstract] [Full Text] [Related]

  • 2. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F, Karadadas N, Ozsener S, Bilgin O.
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR, Puolakka J, Pyörälä T, Luotola H, Bjäörn M, Kääriänen J, Lahdenperä S, Ehnholm C.
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
    [Abstract] [Full Text] [Related]

  • 4. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M, Kahri J, Pyörälä T, Puolakka J, Luotola H, Lappi M, Lahdenperä S, Taskinen MR.
    Atherosclerosis; 1997 Mar 21; 129(2):249-59. PubMed ID: 9105568
    [Abstract] [Full Text] [Related]

  • 5. Postmenopausal bone loss: does HRT always work?
    Stevenson JC, Hillard TC, Lees B, Whitcroft SI, Ellerington MC, Whitehead MI.
    Int J Fertil Menopausal Stud; 1993 Mar 21; 38 Suppl 2():88-91. PubMed ID: 8252111
    [Abstract] [Full Text] [Related]

  • 6. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F, Terek MC, Karadadaş N, Bilgin O.
    J Reprod Med; 2001 Nov 21; 46(11):962-8. PubMed ID: 11762152
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC.
    Obstet Gynecol; 1994 Aug 21; 84(2):222-6. PubMed ID: 8041534
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
    Stevenson JC, Oladipo A, Manassiev N, Whitehead MI, Guilford S, Proudler AJ.
    Br J Haematol; 2004 Mar 21; 124(6):802-8. PubMed ID: 15009069
    [Abstract] [Full Text] [Related]

  • 9. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E, Mälkönen M, Manninen V.
    N Engl J Med; 1981 Mar 05; 304(10):560-3. PubMed ID: 7453723
    [Abstract] [Full Text] [Related]

  • 10. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
    Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI.
    Lancet; 1990 Aug 04; 336(8710):265-9. PubMed ID: 1973969
    [Abstract] [Full Text] [Related]

  • 11. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
    Nerbrand C, Nyberg P, Nordström L, Samsioe G.
    Maturitas; 2002 May 20; 42(1):55-62. PubMed ID: 12020980
    [Abstract] [Full Text] [Related]

  • 12. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O, Lim P, Caubel P.
    Clin Ther; 2000 May 20; 22(5):622-36. PubMed ID: 10868559
    [Abstract] [Full Text] [Related]

  • 13. Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy.
    Darko DA, Dornhorst A, Kennedy G, Mandeno RC, Seed M.
    Diabetes Res Clin Pract; 2001 Dec 20; 54(3):157-64. PubMed ID: 11689270
    [Abstract] [Full Text] [Related]

  • 14. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
    Davidson MH, Maki KC, Marx P, Maki AC, Cyrowski MS, Nanavati N, Arce JC.
    Arch Intern Med; 2000 Nov 27; 160(21):3315-25. PubMed ID: 11088095
    [Abstract] [Full Text] [Related]

  • 15. National differences in lipid response to postmenopausal hormone replacement therapy.
    Ranta V, Oksanen H, Arrenbrecht S, Ylikorkala O.
    Maturitas; 2002 Aug 30; 42(4):259-65. PubMed ID: 12191848
    [Abstract] [Full Text] [Related]

  • 16. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF.
    Fertil Steril; 2001 May 30; 75(5):898-915. PubMed ID: 11334901
    [Abstract] [Full Text] [Related]

  • 17. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep 30; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 18. The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors.
    Tikkanen MJ.
    Maturitas; 1996 Mar 30; 23(2):209-16. PubMed ID: 8735358
    [Abstract] [Full Text] [Related]

  • 19. Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
    Raudaskoski TH, Tomás EI, Paakkari IA, Kauppila AJ, Laatikainen TJ.
    Maturitas; 1995 Jun 30; 22(1):47-53. PubMed ID: 7666816
    [Abstract] [Full Text] [Related]

  • 20. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.
    Crook D, Cust MP, Gangar KF, Worthington M, Hillard TC, Stevenson JC, Whitehead MI, Wynn V.
    Am J Obstet Gynecol; 1992 Mar 30; 166(3):950-5. PubMed ID: 1550171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.